Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,827 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sema6D forward signaling impairs T cell activation and proliferation in head and neck cancer.
Hirai T, Naito Y, Koyama S, Nakanishi Y, Masuhiro K, Izumi M, Kuge T, Naito M, Mizuno Y, Yamaguchi Y, Kang S, Yaga M, Futami Y, Nojima S, Nishide M, Morita T, Kato Y, Tsuda T, Takemoto N, Kinugasa-Katayama Y, Aoshi T, Villa JK, Yamashita K, Enokida T, Hoshi Y, Matsuura K, Tahara M, Takamatsu H, Takeda Y, Inohara H, Kumanogoh A. Hirai T, et al. Among authors: matsuura k. JCI Insight. 2024 Feb 8;9(3):e166349. doi: 10.1172/jci.insight.166349. JCI Insight. 2024. PMID: 38329122 Free PMC article.
Phase I trial of chemoradiotherapy with the combination of S-1 plus cisplatin for patients with unresectable locally advanced squamous cell carcinoma of the head and neck.
Tahara M, Minami H, Kawashima M, Kawada K, Mukai H, Sakuraba M, Matsuura K, Ogino T, Hayashi R, Ohtsu A. Tahara M, et al. Among authors: matsuura k. Cancer Sci. 2011 Feb;102(2):419-24. doi: 10.1111/j.1349-7006.2010.01799.x. Epub 2010 Dec 7. Cancer Sci. 2011. PMID: 21134076 Free article. Clinical Trial.
Phase II feasibility trial of adjuvant chemoradiotherapy with 3-weekly cisplatin for Japanese patients with post-operative high-risk squamous cell carcinoma of the head and neck.
Kiyota N, Tahara M, Okano S, Kawashima M, Matsuura K, Onozawa Y, Nibu K, Hayashi R, Yoshimura K, Ohtsu A. Kiyota N, et al. Among authors: matsuura k. Jpn J Clin Oncol. 2012 Oct;42(10):927-33. doi: 10.1093/jjco/hys128. Epub 2012 Aug 23. Jpn J Clin Oncol. 2012. PMID: 22923484 Clinical Trial.
Phase II trial of chemoradiotherapy with S-1 plus cisplatin for unresectable locally advanced head and neck cancer (JCOG0706).
Tahara M, Kiyota N, Mizusawa J, Nakamura K, Hayashi R, Akimoto T, Hasegawa Y, Iwae S, Monden N, Matsuura K, Fujii H, Onozawa Y, Homma A, Kubota A, Fukuda H, Fujii M. Tahara M, et al. Among authors: matsuura k. Cancer Sci. 2015 Jun;106(6):726-733. doi: 10.1111/cas.12657. Epub 2015 Apr 1. Cancer Sci. 2015. PMID: 25781202 Free PMC article. Clinical Trial.
Clinical impact of cachexia in unresectable locally advanced head and neck cancer: supplementary analysis of a phase II trial (JCOG0706-S2).
Matsuzuka T, Kiyota N, Mizusawa J, Akimoto T, Fujii M, Hasegawa Y, Iwae S, Monden N, Matsuura K, Onozawa Y, Hayashi R, Tahara M; Japan Clinical Oncology Group(JCOG) Head and Neck Cancer Study Group. Matsuzuka T, et al. Among authors: matsuura k. Jpn J Clin Oncol. 2019 Jan 1;49(1):37-41. doi: 10.1093/jjco/hyy145. Jpn J Clin Oncol. 2019. PMID: 30364985 Clinical Trial.
A review of head and neck cancer staging system in the TNM classification of malignant tumors (eighth edition).
Head and Neck Cancer Study Group (HNCSG); Monden N, Asakage T, Kiyota N, Homma A, Matsuura K, Hanai N, Kodaira T, Zenda S, Fujii H, Tahara M, Yokota T, Akimoto T, Iwae S, Onitsuka T, Ogawa T, Okano S, Takahashi S, Shimizu Y, Yonezawa K, Hayashi R. Head and Neck Cancer Study Group (HNCSG), et al. Among authors: matsuura k. Jpn J Clin Oncol. 2019 Jul 1;49(7):589-595. doi: 10.1093/jjco/hyz052. Jpn J Clin Oncol. 2019. PMID: 31194232 Review.
Nutritional support dependence after curative chemoradiotherapy in head and neck cancer: supplementary analysis of a phase II trial (JCOG0706S1).
Imamura Y, Kiyota N, Ogawa G, Akimoto T, Fujii M, Hanai N, Iwae S, Monden N, Matsuura K, Onozawa Y, Hayashi R, Tahara M; Japan Clinical Oncology Group (JCOG) Head and Neck Cancer Study Group. Imamura Y, et al. Among authors: matsuura k. Jpn J Clin Oncol. 2019 Dec 18;49(11):1009-1015. doi: 10.1093/jjco/hyz121. Jpn J Clin Oncol. 2019. PMID: 31665358 Clinical Trial.
Immunotherapy for squamous cell carcinoma of the head and neck.
Yokota T, Homma A, Kiyota N, Tahara M, Hanai N, Asakage T, Matsuura K, Ogawa T, Saito Y, Sano D, Kodaira T, Motegi A, Yasuda K, Takahashi S, Tanaka K, Onoe T, Okano S, Imamura Y, Ariizumi Y, Hayashi R; Japan Clinical Oncology Group (JCOG) Head and Neck Cancer Study Group. Yokota T, et al. Among authors: matsuura k. Jpn J Clin Oncol. 2020 Sep 28;50(10):1089-1096. doi: 10.1093/jjco/hyaa139. Jpn J Clin Oncol. 2020. PMID: 32776100 Review.
1,827 results